Please login to the form below

Not currently logged in
Email:
Password:
I have forgotten my password

personalised medicine

This page shows the latest personalised medicine news and features for those working in and with pharma, biotech and healthcare.

The Directory and digital round-up

The Directory and digital round-up

Kyomed re-brands and launches new app. Kyomed, a French company offering services in connected healthcare, autonomy and personalised medicine, marks its fourth anniversary, rebranding to KYomed INNOV. ... The new app is powered by artificial intelligence

Latest news

  • Revolutionising how healthcare is delivered Revolutionising how healthcare is delivered

    Imagine if a shipment holding medicine that was personalised for the DNA of a cancer patient was spoiled or stolen. ... The complete visibility of healthcare shipments is needed as medicines become more personalised and more potent.

  • NICE: We're the institute of 'yes' NICE: We're the institute of 'yes'

    Personalised medicine challenges. The QuintilesIMS meeting also discussed the scale of the health technology assessment challenge presented by personalised medicines, particularly in oncology. ... At the moment personalised medicine scares us, because

  • NICE backs Europe's first stem cell therapy NICE backs Europe's first stem cell therapy

    We are delighted that NICE has recommended that eligible patients have access to this personalised and regenerative medicine for a rare and seriously debilitating orphan condition," commented Chiesi's UK managing

  • EMA starts firming up its stance on personalised medicines EMA starts firming up its stance on personalised medicines

    New draft European guidelines on personalised medicines and companion diagnostics are expected to be released by December 2018. ... a personalised medicine.

  • Keytruda is first FDA-approved drug for molecular indication Keytruda is first FDA-approved drug for molecular indication

    Keytruda is first FDA-approved drug for molecular indication. Indicates a significant development in the shift towards personalised medicine. ... month, although he noted that the development was very significant in the context of the shift towards

More from news
Approximately 8 fully matching, plus 118 partially matching documents found.

Latest Intelligence

  • Cancer in The Information Age: are we illuminated or inundated? Cancer in The Information Age: are we illuminated or inundated?

    Personalised vs personal medicine. Data and information have already proved fruitful in the clinic, yielding the advent of personalised cancer medicine,. ... But for all the promise of personalised medicine, it can limit perspective, drawing clinical

  • The challenges of making genomics a reality for patients The challenges of making genomics a reality for patients

    It ushered in a new era of what we now call personalised medicine. ... To put this in context, developing the first cystic fibrosis medicine that treats the underlying cause took.

  • Bridging pharma’s digital gap Bridging pharma’s digital gap

    The rise of sophisticated technology assisting in the creation of personalised medicine would be naming just one example that came as a great leap for both the industry and mainstream medicine. ... The desire for customers to have personalised content

  • The challenges of making genomics a reality for patients today, not tomorrow The challenges of making genomics a reality for patients today, not tomorrow

    It ushered in a new era of what we now call personalised medicine. ... Fast-forward 18 years and more than ever we see the potential of how precision medicine could transform care.

  • The real-world data conundrum The real-world data conundrum

    No matter how we look at it, our approaches towards medicine are changing. ... At the core of this spectrum are patients. As the understanding of stratified, personalised medicine has grown over the last decade, a promise has emerged that there will be a

More from intelligence
Approximately 4 fully matching, plus 24 partially matching documents found.

Latest appointments

  • Stephen Eck joins Aravive Biologics Stephen Eck joins Aravive Biologics

    chairman of the board of directors of the Personalised Medicine Coalition.

  • FlowMetric Diagnostics names president FlowMetric Diagnostics names president

    It is a great time for the development of new flow cytometry-based companion diagnostics which can help advance personalised medicine and better meet the needs of physicians, healthcare workers and

  • GlobalData makes Americas appointment GlobalData makes Americas appointment

    Dr Bonnie Bain, global head of healthcare at GlobalData, adds: “ Sean is widely recognised as an expert and thought leader in personalised and translational medicine, and it's great to welcome

  • Roche appoints new oncology research head Roche appoints new oncology research head

    Personalised cancer has been his forte, however, and he has served as director of personalised cancer medicine at Vanderbilt. ... I was particularly attracted to Roche as one of the pioneers and front-runners in personalised medicine, as the world's top

  • Former FDA adviser joins Precision for Medicine Former FDA adviser joins Precision for Medicine

    Former FDA adviser joins Precision for Medicine. Vicki Seyfert-Margolis appointed chief of science and strategy at life science research company. ... During this time, she led the FDA's regulatory science and personalised medicine initiative, as well as

More from appointments
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 2 fully matching, plus 4 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kantar Health

Kantar Health is a leading global healthcare consulting firm and trusted advisor to many of the world’s leading pharmaceutical, biotech,...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Quick links

Infographics

Multimedia